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Five Ag(I) complexes containing the ligands bis(imidazol-2-yl)methane (2-BIM) and its derivatives were prepared and [Ag2(2-
BIM)2](ClO4)2 and [Ag2(2-BIM(Bz)OH)2](ClO4)2 EtOH were characterised using X-ray crystallography. In each dimer the two
Ag(I) ions are two-coordinate and there are small but definite argentophilic Ag–Ag (d10–d10) interactions. All of the complexes
display anti-fungal activity when tested in vitro against the fungal pathogen Candida albicans.
 2004 Elsevier Ltd. All rights reserved.
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In our efforts to develop new metal complexes that
would greatly inhibit the growth of the human fungal
pathogen Candida albicans [1–4] we have found that, to
date, the most active drug tested in aqueous media is the
Ag(I) complex [Ag(phendio)2]ClO4 (phendio¼ 1,10-
phenanthroline-5,6-dione) [5]. As part of these ongoing
studies into the synthesis and in vitro testing of newmetal-
based anti-fungal drugs we report here the preparation of
five Ag(I) complexes containing bis(imidazole) ligands.
Bis(imidazol-2-yl)methane (2-BIM) and its derivatives
(Fig. 1), in which the two imidazole rings are linked via a
single tetrahedral carbon atom, can be viewed as primitive
models for multi-histidine coordination in biological
systems. Such bis(imidazole) ligands have been shown to
form stable six-membered chelate rings with a variety of
transition metals [6–12], and the Pt(II) complex [Pt(2-
BIM(Me)OH)Cl2] (2-BIM(Me)OH¼ bis(N-methylim-* Corresponding author. Tel.: +353-1-708-3767; fax: +353-1-708-
3815.
E-mail address: mmcann@may.ie (M. McCann).
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doi:10.1016/j.poly.2004.02.006idazol-2-yl)carbinol) [10] has been reported to exhibit
notable antitumor activity.2. Results and discussion
In the current study, AgClO4 was reacted at room
temperature with methanolic solutions of the five
bis(imidazole) ligands shown in Fig. 1 to give the re-
spective Ag(I) complex in moderate to good yield. The
complexes were soluble in hot acetonitrile and DMSO
and insoluble in water. The X-ray crystal structure of
[Ag2(2-BIM)2](ClO4)2 (Fig. 2 and Table 1) showed the
complex to be centrosymmetric, containing two Ag(2-
BIM)þ units. The two metal ions are two-coordinate
and have identical atoms in the plane of the chelating
ligand. Using its two imine N atoms each 2-BIM ligand
bridges the pair of Ag(I) ions. All four N atoms (N1,
N4A, N4, N1A) are coplanar and the two imidazole
groups in each 2-BIM ligand have an interplanar angle
of 75.52(8). The two Ag(I) ions are only weakly inter-
acting, the distance separating them being 3.2612(4) A.
The binding of the two 2-BIM ligands is similar to that
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Fig. 1. Ligand symbols and structures.
Table 1
Selected bond lengths (A) and angles () for [Ag2(2-BIM)2](ClO4)2
Bond lengths (A)
Ag(1)–N(4)#1 2.0953(17)
Ag(1)–N(1) 2.0957(17)
Ag(1)–Ag(1)#1 3.2612(4)
Ag(1)–O(11)#2 2.965(2)
Ag(1)–O(11)#3 3.264(2)
Bond angles ()
N(4)#1–Ag(1)–N(1) 167.80(7)
N(4)#1–Ag(1)–Ag(1)#1 91.08(5)
N(1)–Ag(1)–Ag(1)#1 99.94(5)
Symmetry transformations used to generate equivalent atoms: #1
xþ 1;y þ 1;zþ 1; #2 1þ x; 1þ y; z; #3 1 x;y; 1 z.
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olate) in the heteropolynuclear complex, [{Ru(pap)2
(Biim)}2Ag2](ClO4)2 H2O (pap¼ 2-(phenylazo)pyri-
dine) [13]. The shorter Ag–Ag separation in the latter
species is (2.8899 A) is mainly a consequence of the
smaller size of the Biim2 ligand compared to 2-BIM
(no methylene bridge between the two imidazole rings in
Biim2). The formula unit of [Ag2(2-BIM)2](ClO4)2 is
completed by two lattice perchlorate, which are involved
in hydrogen bonding to the hydrogen atoms of the im-
idazole nitrogen atoms (N2 and N3, and N2A and N3A,
respectively). The lattice perchlorate anions show un-
symmetric bridging interactions with Ag(I) ions of
neighbouring cations (AgOClO3 2.965(2) and 3.264(2)
A). There are hydrogen bonding interactions along the a
and b directions which link the units together in the
lattice, forming sheets. However, there are no hydrogen
bonds in the c direction, that is to say, between the
sheets. There are some intermolecular p–p interactions
involving the imidazole rings on adjacent dimer mole-
cules and there is also evidence of some interdimer
C–H   p interactions between neighbouring imidazole
functions. A perspective view of the cell packing is
shown in Fig. 3.
The X-ray crystal structure of [Ag2(2-BIM(Bz)-
OH)2](ClO4)2 EtOH (Fig. 4 and Table 2) shows the
asymmetric unit containing one [Ag2(2-BIM(Bz)-
OH)2]
2þ unit, two perchlorate anions and a solvate
ethanol. The two Ag(I) ions are again bridged by the
two ligands and each metal is approximately linearly
coordinated to a pair of imine nitrogens. There are ad-Fig. 2. X-ray crystal structure oditional longer interactions with the perchlorate anions.
The metal-metal distance of 3.018(4) A is considerably
shorter than in [Ag2(2-BIM)2](ClO4)2. Within the
[Ag2(2-BIM(Bz)OH)2](ClO4)2 EtOH complex molecule
there appears to be some degree of intramolecular p–p
interaction between the imidazole and phenyl rings of
the opposing two 2-BIM(Bz)OH ligands in the dimer.
Interestingly, the angles N(1A)–Ag(1)–Ag(2) and
N(4B)–Ag(1)–Ag(2) are very different to one another
(168.30(12) and 68.35(8), respectively). One of the
perchlorate anions in the complex is disordered and was
modeled with two alternative sets of oxygen atom po-
sitions (50% occupancy each). The ethanol solvate is
also disordered and was modeled as 50% occupancy of
two alternative positions. Hydrogen atoms attached to
carbon were inserted at calculated positions, whilst
those attached to the 2-BIM(Bz)OH alcohol groups
were located from difference maps and not further re-
fined, those bonded to the disordered oxygen atom of
the ethanol solvate were not located or included in the
model. One view of the packing in the crystal is illus-
trated in Fig. 5.
Repeated attempts to grow crystals of [Ag2{2-BIM
(Me)}2](ClO4)2, [Ag2{2-BIM(CN)}2](ClO4)2 and [Ag2{2-
BIM(BzCl)}2](ClO4)2 suitable for X-ray structural anal-f [Ag2(2-BIM)2](ClO4)2.
Fig. 4. X-ray crystal structure of [Ag2(2-BIM(Bz)OH)2](ClO4)2 EtOH.
Fig. 3. Packing diagram for [Ag2(2-BIM)2](ClO4)2.
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ities in the core structures of all five bis(imidazole) ligands
the latter three silver complexes are thought to be essen-
tially isostructural with [Ag2(2-BIM)2] (ClO4)2 and
[Ag2(2-BIM(Bz)OH)2](ClO4)2 EtOH and are thus also
formulated as dimers. For [Ag2{2-BIM(CN)}2](ClO4)2
there is also the possibility of the pendant cyano groups
participating in the bonding to themetal since Ag(I) has a
high affinity for organonitrile donors.2.1. In vitro anti-Candida studies
All of the metal-free bis(imidazole) ligands and the
Ag(I) complexes were screened for their ability to inhibit
the growth of C. albicans. The minimum inhibitory
concentration (MIC) is the concentration of drug (ex-
pressed as lg of complex per 1 cm3 of aqueous growth
medium solution) required to totally inhibit the growth
of the fungal cells at 37 C. As the complexes and the
Table 2
Selected bond lengths (A) and angles () for [Ag2(2-BIM(Bz)OH)2]
(ClO4)2 EtOH
Bond lengths (A)
Ag(1)–N(1A) 2.111(3)
Ag(1)–N(4B) 2.134(3)
Ag(1)–Ag(2) 3.0184(4)
Ag(1)–O(11) 3.211(6)
Ag(1)–O(13) 3.312(7)
Ag(2)–N(1B) 2.119(3)
Ag(2)–N(4A) 2.141(3)
Ag(2)–O(21) 3.012(7)
Ag(2)–O(210) 3.234(14)
Bond angles ()
N(1A)–Ag(1)–N(4B) 168.30(12)
N(1A)–Ag(1)–Ag(2) 103.65(8)
N(4B)–Ag(1)–Ag(2) 68.35(8)
N(1A)–Ag(1)–O(11) 82.69(13)
N(4B)–Ag(1)–O(11) 105.55(13)
Ag(2)–Ag(1)–O(11) 173.58(10)
N(1A)–Ag(1)–O(13) 109.69(14)
N(4B)–Ag(1)–O(13) 81.74(14)
Ag(2)–Ag(1)–O(13) 133.53(10)
O(11)–Ag(1)–O(13) 41.35(13)
N(1B)–Ag(2)–N(4A) 172.79(12)
N(1B)–Ag(2)–O(21) 92.53(19)
N(4A)–Ag(2)–O(21) 93.9(2)
N(1B)–Ag(2)–Ag(1) 99.97(8)
N(4A)–Ag(2)–Ag(1) 74.23(8)
O(21)–Ag(2)–Ag(1) 164.88(17)
N(1B)–Ag(2)–O(210) 76.8(2)
N(4A)–Ag(2)–O(210) 109.3(2)
Ag(1)–Ag(2)–O(210) 174.4(2)
Fig. 5. Packing diagram for [Ag2(2-BIM(Bz)OH)2](ClO4)2 EtOH.
1252 S. Abuskhuna et al. / Polyhedron 23 (2004) 1249–1255ligands were essentially water insoluble the tests were
carried out as suspensions of the complexes in the
aqueous growth medium. In addition, because the
complexes were soluble in DMSO a series of anti-fungaltests were also conducted using DMSO/water solutions
of the complexes (see Section 3). In all cases, the activity
of the complexes were compared to that of a control
system in which the cells were grown in the absence of
any added complex or free ligand (under these condi-
tions the fungal cell replication was rapid). In addition,
under the present biological test conditions an aqueous
suspension of the anti-Candida prescription drug keto-
conazole had an MIC value of ca. 2.5 lg cm3.
All of the metal-free ligands were found to be inactive
against the fungal cells. As aqueous suspensions, the
silver complexes were moderately active with MIC value
ranges indicated in brackets: [Ag2(2-BIM)2](ClO4)2 (10–
20 lg cm3); [Ag2(2-BIM(Bz)OH)2](ClO4)2 EtOH (50–
100 lg cm3); [Ag2{2-BIM(Me)}2](ClO4)2 (20–50
lg cm3); [Ag2{2-BIM(CN)}2](ClO4)2 (20–50 lg cm3).
A considerable improvement in anti-fungal activity was
observed upon administering the complexes as DMSO/
water solutions as opposed to aqueous suspensions:
[Ag2(2-BIM)2](ClO4)2 (5–10 lg cm3); [Ag2(2-BIM(Bz)-
OH)2](ClO4)2 EtOH (2.5–5 lg cm3); [Ag2{2-BIM
(Me)}2](ClO4)2 (2.5–5 lg cm3); [Ag2{2-BIM(CN)}2]
(ClO4)2 (5–10 lg cm3); [Ag2{2-BIM(BzCl)}2](ClO4)2
(5–10 lg cm3). Besides greatly increasing the solubility
of the complexes the DMSO is also thought to make the
cells more permeable to the complexes so that they can
enter the cells and exert their effects on the organism. In
comparison, as an aqueous suspension [Ag(phen-
dio)2]ClO4 has an MIC value of 0.3 lg cm3 [5].3. Experimental
Chemicals were purchased from commercial sources
and, unless specified, were used without further purifi-
cation. Literature methods were used to prepare 2-BIM
[14,15], 2-BIM(Me) [7,16] and 2-BIM(OH)Bz [17]. The
preparation of the silver complexes was conducted in the
absence of light and the samples were stored in the dark.
Infrared spectra of solids (in a KBr matrix) were re-
corded in the region 4000–400 cm1 on a Nicolet FT-IR
Impact 400D infrared spectrometer and 1H NMR
spectra were run on a Bruker Avance 300 MHz instru-
ment. Microanalytical data were provided by the Mi-
croanalytical Laboratory, National University of
Ireland, Cork, Ireland.
3.1. 2-BIM(CN)
Acrylonitrile (3.6 g, 67 mmol) was added to a mixture
of 2-BIM (5.0 g, 34 mmol), and triethylamine (6.8 g, 67
mmol) in acetonitrile (150 cm3). The reaction mixture
was refluxed with stirring for 5 h. The solvent was re-
moved under reduced pressure giving a white solid,
which was recrystallised from acetone. Yield: 4.7 g
(55%). Mp 170 C. Anal. Calc. C, 61.40; H, 5.50; N,
S. Abuskhuna et al. / Polyhedron 23 (2004) 1249–1255 125333.07. Found: C, 61.26; H, 5.47; N, 32.76%. 1H
NMR(DMSO-d6): 7.17 (2H, d, J ¼ 1:3 Hz), 6.8 (2H, d,
J ¼ 1:3 Hz), 4.3 (4H, t, J ¼ 6:7 Hz), 4.2 (2H, s), 3.0 (4H,
t, J ¼ 6:7 Hz) ppm. 13C NMR(DMSO-d6): 143.6, 127.3,
120.8, 118.8, 25.4, 19.2 ppm. IR: 3125, 2932, 2264, 1485,
1447, 1383, 1287, 1166, 1134, 1089, 926, 722, 743, 705
cm1. Mass spec.: m=z: 254 (Mþ, 4%), 200 (4), 173 (8),
161 (6), 148 (10), 134 (11), 120 (14), 107 (14), 94 (28), 82
(84), 66 (20), 54 (100).
3.2. 2-BIM(BzCl)
2,6-Dichlorobenzyl chloride (0.53 g, 2.7 mmol) was
added to a stirred mixture of 2-BIM (0.2 g, 1.3 mmol)
and sodium hydride (0.06 g, 2.5 mmol) in dry DMF (15
cm3). The mixture was stirred overnight at room tem-
perature and the solvent removed under reduced pres-
sure. Water (20 cm3) was added and the product
extracted with dichloromethane, and the dichlorome-
thane solution was then dried over magnesium sulphate.
After filtration the solvent was removed under reduced
pressure. The resulting brown oily residue was digested
in cyclohexane and the white product precipitated upon
cooling. Yield: 0.34 g (54%). Mp 93 C. Anal. Calc. C,
54.10; H, 3.43; N, 12.02. Found: C, 54.09; H, 3.58; N,
11.73%. 1H NMR (CDCl3): 7.4 (2H, d, J ¼ 2 Hz), 7.1
(2H, dd, J ¼ 8:3 Hz), 6.9 (2H, d, J ¼ 1:3 Hz), 6.7 (2H, d,
J ¼ 1:3 Hz), 6.5 (2H, d, J ¼ 8:3 Hz), 5.2 (4H, s), 4.2
(2H, s). 13C NMR (CDCl3): 143, 134.5, 133.6, 132.7,
129.5, 129.1, 128.1, 127.5, 120.5, 47, 27 ppm. IR: 2945,
1593, 1485, 1447, 1389, 1274, 1121, 1057, 849, 733, 682
cm1. Mass spec.: m=z: 466 (Mþ, 16%), 429 (4), 305 (26),
269 (8), 205 (8), 159 (100), 147 (8), 123 (16), 99 (6), 89
(16), 81 (38), 63 (10).
3.3. [Ag2(2-BIM)2](ClO4)2
Silver perchlorate (0.70 g, 3.37 mmol) was added to a
stirred solution of 2-BIM (0.5 g, 3.37 mmol) in methanol
(15 cm3) and the mixture stirred for 1 h at room tem-
perature. The precipitated white was filtered off, washed
with methanol and air-dried. Yield: 1.00 g (83%). Anal.
Calc. C, 23.64; H, 2.25; N, 15.76. Found: C, 23.58; H,
2.13; N, 15.78%. IR: 3344, 3151, 1293, 1095, 759, 624
cm1. 1H NMR (ppm DMSO): 6.8 (8H, s), 4 (4H, s).
The complex was soluble in hot acetonitrile and DMSO,
and crystals suitable for X-ray analysis were obtained by
recrystallising from acetonitrile.
3.4. [Ag2(2-BIM(Bz)OH)2](ClO4)2 EtOH
This white complex was prepared and recrystallised in
a similar way to [Ag2(2-BIM)2](ClO4)2 using silver per-
chlorate (0.06 g, 0.17 mmol) and 2-BIM(Bz)OH (0.1 g,
0.29 mmol). Yield: 0.11 g (68%). Anal. Calc. C, 43.87; H,
3.48; N, 9.70. Found: C, 44.21; H, 3.45; N, 9.69%. IR:2485, 3138, 2971, 1497, 1459, 1287, 1102, 827, 717, 624
cm1. 1H NMR (ppm DMSO): 5.2 (8H, dd), 6.4 (2H, d),
7.1 (8H, s), 7.35 (20H, m). The complex was soluble in
hot acetonitrile, hot acetone and DMSO.
3.5. [Ag2{2-BIM(Me)}2](ClO4)2
To a solution of silver perchlorate (0.10 g, 0.48 mmol)
in methanol (3 cm3) was added a solution of 2-BIM(Me)
(0.10 g, 0.56 mmol) in methanol (3 cm3). A white pre-
cipitate formed immediately and the reaction mixture
was stirred for 20 min at room temperature. The white
product was filtered off, washed with methanol and then
dried in air. Yield: 0.13 g (62%). Anal. Calc. C, 28.10; H,
3.13; N, 14.60. Found: C, 27.5; H, 3.00; N, 14.13%. IR:
3485, 3138, 2971, 1497, 1414, 1293, 1102, 772, 627 cm1.
1H NMR (ppm DMSO): 3.5 (12H, s), 4.36 (4H, s), 6.8
(4H, s), 7.2 (4H, s). The complex was soluble in hot
acetonitrile, hot acetone and DMSO.
3.6. [Ag2{2-BIM(CN)}2](ClO4)2
This white complex was prepared in a similar way to
[Ag2{2-BIM(Me)}2](ClO4)2 using silver perchlorate
(0.10 g, 0.48 mmol) and 2-BIM(CN) (0.20 g, 0.78 mmol).
Yield: 0.32 g (89%). Anal. Calc. C, 33.81; H, 3.03; N,
18.20. Found: C, 33.46; H, 2.92; N, 18.20%. IR: 3511,
3138, 2984, 2264, 1497, 1427, 1287, 1102, 756, 627 cm1.
1H NMR (ppm DMSO): 7.3 (4H, s), 6.8 (4H, s), 4.4 (4H,
s), 4.2 (8H, t), 2.9 (8H, t). The complex was soluble in
hot acetonitrile, hot acetone and DMSO.
3.7. [Ag2{2-BIM(BzCl)}2](ClO4)2
This white complex was prepared in a similar way to
[Ag2{2-BIM(Me)}2](ClO4)2 using silver perchlorate
(0.08 g, 0.38 mmol) in 3 ml methanol was added to 2-
BIM(BzCl) (0.20 g, 0.43 mmol). Yield: 0.16 g (57%).
Anal. Calc. C, 37.43; H, 2.37; N, 8.31. Found: C, 37.03;
H, 2.41; N, 8.04%. IR: 3511, 3138, 1593, 1491, 1395,
1274, 1102, 836, 749, 628 cm1. 1H NMR (ppm
DMSO): 7.9 (4H, d), 7.56 (4H, dd), 7.5 (4H, d),7.25 (4H,
d) 6.8 (4H, d), 5.5 (8H, s), 4.8 (4H, s). The complex was
soluble in hot acetonitrile, hot acetone and DMSO.
3.8. Anti-Candida testing
Candida albicans ATCC 10231 was obtained from the
American Type Culture Collection (Manasas, VA,
USA). Cultures were grown on Sabouraud dextrose
agar (SDA) plates at 37 C and maintained at 4 C for
short-term storage. Minimum inhibitory concentrations
(MICs) were determined as follows. RPMI-1640 broth
medium was used for the anti-Candida susceptibility
testing. RPMI (5.15 g) was dissolved in cold distilled
water (425 cm3) in a 1-l Duran bottle and the pH
1254 S. Abuskhuna et al. / Polyhedron 23 (2004) 1249–1255adjusted to 4.0 using a few drops of HCl (ca. 2 M). The
resulting solution was autoclaved and then allowed to
cool to approximately 50 C. Morpholinepropanesulf-
onic acid (MOPS) (17.3 g) and L-glutamate (0.15 g) were
dissolved together with stirring in distilled water (50
cm3) and the resulting solution filter sterilized. The
MOPS and L-glutamate solution was added to the warm
RPMI and the pH of the mixture adjusted to 7.0 using
sterile NaOH (6 M). Prior to MIC testing, cells were
grown on SDA at 37 C for 24 h. Cell suspensions were
prepared in sterile phosphate buffered saline (PBS, pH
7.2) and cells were counted microscopically following
dilution with PBS. A microtitre plate was inoculated
with cells at a density of 5 105 cells cm3. Test sus-
pensions (in water) and solutions (in aqueous DMSO) of
the silver complexes were each prepared as follows.
Suspensions in water: the complex (0.02 g) was sus-
pended in distilled water (10 cm3) to yield a stock sus-
pension of concentration 2000 lg cm3. Doubling
dilutions of the stock suspension were made to yield a
series of test suspensions ranging in complex concen-
tration from 20 to 1.25 lg cm3. Solutions in DMSO: the
complex (0.02 g) was dissolved in DMSO (10 cm3) to
yield a stock solution of concentration 2000 lg cm3.
Doubling dilutions of the stock solution were made
using distilled water to yield a series of test solutions
ranging in complex concentration from 20 to 1.25
lg cm3. The DMSO concentration (% v/v) in the test
solutions ranged from 1.0% to 0.06% (note that a 2%
DMSO aqueous solution, without added complex, does
not inhibit the growth of the microorganism whereas a
3% DMSO aqueous solution will arrest cell growth to-Table 3
X-ray crystallographic data. Crystal data and structure refinement for [Ag2(
Identification code [Ag2(2-BIM)2](ClO
Empirical formula C14H16Ag2Cl2N8O8
Formula weight 710.99
Crystal system triclinic
Space group P1
a (A) 7.8149(10)
b (A) 8.9902(11)
c (A) 9.2559(11)
a () 108.046(2)
b () 98.283(2)
c () 114.763(2)
Volume (A3) 532.47(11)
Z 1
F (0 0 0) 348
Crystal size (mm) 0.16 0.25 0.31
h range for data collection () 2.44–28.65
Reflections collected 4544
Independent reflections [RðintÞ] 2396 [0.0186]
Absorption correction multiscan
Maximum and minimum transmission 1.0000 and 0.8116
Data/restraints/parameters 2396/0/154
R1, wR2 [I > 2rðIÞ] 0.0198, 0.0526
R1, wR2 (all data) 0.0204, 0.0530tally). For the aqueous test suspensions and the aque-
ous-DMSO test solutions the complex/cell mixtures
were incubated at 37 C for 24 h with continuous
shaking and the assays were performed in triplicate.
Plates were read using a Labsystems iEMS Reader MF
(absorbance at k ¼ 540 nm) and data were statistically
analysed.
3.9. X-ray crystallography
All of the data were collected at 150 K on a Bruker
SMART 1000 diffractometer using Mo Ka radiation
(k ¼ 0:71073 A). The structures were solved by direct
methods and refined by full-matrix least-squares on F 2
using all the reflections. One of the prechlorate anions in
[Ag2(2-BIM(Bz)OH)2](ClO4)2 EtOH is disordered and
was modeled with two alternative sets of oxygen atom
positions (50% occupancy each). The ethanol solvate is
also disordered and was modeled as 50% occupancy of
two alternative positions. All non-hydrogen atoms were
refined with anisotropic atomic displacement parame-
ters and hydrogen atoms bonded to carbon were in-
serted at calculated positions. Hydrogen atoms bonded
to nitrogen ([Ag2(2-BIM)2](ClO4)2) or the ligand alco-
hol group ([Ag2(2-BIM(Bz)OH)2](ClO4)2 EtOH) were
located from difference maps and not further refined;
those bonded to the disordered oxygen of the ethanol
solvate in [Ag2(2-BIM(Bz)OH)2](ClO4)2 EtOH were
not included in the model. All programmes used in the
structure solution and refinement are included in the
SHELXTL package [18] and data collection and refine-
ment details are summarised in Table 3.2-BIM)2](ClO4)2 and [Ag2(2-BIM(Bz)OH)2](ClO4)2 EtOH
4)2 [Ag2(2-BIM(Bz)OH)2](ClO4)2 EtOH
C44H46Ag2Cl2N8O11
1149.53
triclinic
P1
10.9636(7)
14.7743(9)
16.0180(10)
114.3870(10)
98.2900(10)
95.8410(10)
2300.6(2)
2
1164
0.37 0.25 0.14
1.54–25.00
16522
8050 [0.0159]
multiscan
1.000000 and 0.912980
8050/98/667
0.0356, 0.0877
0.0455, 0.0942
S. Abuskhuna et al. / Polyhedron 23 (2004) 1249–1255 12554. Supplementary data
X-ray supplementary data for [Ag2(2-BIM)2](ClO4)2
and [Ag2(2-BIM(Bz)OH)2](ClO4)2 EtOH are available
from the Cambridge Crystallographic Data Centre, 12
Union Road, Cambridge CB2 1EZ, England (fax: +44-
1223-336033; E-mail: deposit@ccdc.cam.ac.uk or www:
http://www.ccdc.cam.ac.uk), on request quoting the de-
position numbers CCDC 219908 and CCDC 219909,
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